Tailored Antiplatelet Therapy Following PCI

PHASE4CompletedINTERVENTIONAL
Enrollment

5,276

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

October 31, 2020

Study Completion Date

October 31, 2020

Conditions
Coronary Artery DiseaseAcute Coronary SyndromeStenosis
Interventions
DRUG

Clopidogrel

One 75 mg tablet per day by mouth for one year

DRUG

Ticagrelor

One 90 mg tablet twice per day by mouth for one year

Trial Locations (41)

10016

New York University Langone Medical Center, New York

10032

Columbia University Medical Center, New York

11030

The Feinstein Institute for Medical Research, Manhasset

11501

Winthrop University Hospital, Mineola

12208

Albany Medical College, Albany

12309

Cardiology Associates of Schenectady, Schenectady

29605

Greenville Health System, Greenville

32224

Mayo Clinic in Florida, Jacksonville

34102

NCH Heart Institute, Naples

39216

The University of Mississippi Medical Center, Jackson

41017

St. Elizabeth Healthcare, Crestview Hills

48202

Henry Ford Hospital, Detroit

53215

Aurora Health Care, Milwaukee

54601

Mayo Clinic Health System, La Crosse

54702

MHS, Eau Claire, Eau Claire

55407

Minneapolis Heart Institute, Minneapolis

55455

University of Minnesota, Minneapolis

55805

Essentia Institute of Rural Health, Duluth

55905

Mayo Clinic in Rochester, Rochester

60153

Loyola University Medical Center, Maywood

60201

NorthShore University Health System, Evanston

85259

Mayo Clinic in Arizona, Scottsdale

92123

Sharp HealthCare, San Diego

94110

Zuckerberg San Francisco General, San Francisco

02903

Rhode Island Hospital, Providence

02906

The Miriam Hospital, Providence

V5N 3W9

Vancouver General Hospital, UBC Division of Cardiology, Vancouver

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

P7B 6V4

Thunder Bay Regional Health Sciences Centre, Thunder Bay

M3M 0B2

Humber River Hospital, Toronto

M4N 3M5

Sunnybrook Health Services Center, Toronto

M5B 1W8

St Michael's Hospital, Toronto

M5B 2C4

Toronto General Hospital - UHN, Toronto

S4P 0W5

Regina General Hospital, Regina

02990

Hospital de Especialidades, Centro Medico Nacional 'La Raza', Mexico City

03100

Hospital REgional No. 1, Mexico City

06720

Hospital de Cardiologia, Centro Medico Nacional Siglo XXI, Mexico City

302-718

Konyang University College of Medicine, Daejeon

501-757

Chonnam National University Hospital, Gwangju

Unknown

Ajou University Hospital, Gyeonggi-do

156-755

Chung-Ang University Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Spartan Bioscience Inc.

INDUSTRY

collaborator

Applied Health Research Centre

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Mayo Clinic

OTHER

NCT01742117 - Tailored Antiplatelet Therapy Following PCI | Biotech Hunter | Biotech Hunter